logo
Select company
Select metric
Ticker Information

Ticker

CELU

Company Name

CELULARITY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CELULARITY INC - Enterprise Value over EBITDA Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CELU - EV/EBITDA Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)Enterprise ValueEnterprise Value over EBITDA
6/30/2025$ -58.15M$ 164.38M0
12/31/2024$ -43.55M$ 97.61M0
9/30/2024$ -21.41M$ 111.83M0
6/30/2024$ -99.58M$ 124.73M0
3/31/2024$ -141.23M$ 115.23M0
12/31/2023$ -183.96M$ 120.99M0
9/30/2023$ -169.66M$ 100.43M0
6/30/2023$ -71.91M$ 103.8M0
3/31/2023$ 22.77M$ 162.26M7.13
12/31/2022$ 23.58M$ 139.05M5.9
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CELULARITY INC's latest trailing twelve months (TTM) EV/EBITDA stands at 183.46.
  • Over the past 5 years, CELULARITY INC's average EV/EBITDA has been 51.63.
  • The median EV/EBITDA for CELULARITY INC during this period was 8.57
  • CELULARITY INC reached its highest EV/EBITDA over the past 5 years at 183.46.
  • The lowest EV/EBITDA recorded by CELULARITY INC in the same timeframe 5.9

CELULARITY INC's EV/EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBITDA Benchmarks
CompanyEV/EBITDA
IVVD : INVIVYD INC -SPRO : SPERO THERAPEUTICS INC -CSBR : CHAMPIONS ONCOLOGY INC 24.86DOMH : DOMINARI HOLDINGS INC -PLX : PROTALIX BIOTHERAPEUTICS INC 10.3MGX : METAGENOMI INC -SEER : SEER INC -WHWK : WHITEHAWK THERAPEUTICS INC -THTX : THERATECHNOLOGIES INC 23.16FBIO : FORTRESS BIOTECH INC 8.44

Definition of Enterprise Value over EBITDA

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for CELULARITY INC is calculated as follows: EV [ $ 371.86M ] / EBITDA [ $ 2.03M ]
(=) EV/EBITDA [ 183.46 ]

CELU - Enterprise Value over EBITDA, Last 5 years

5.9

Minimum

Dec 31, 2022

183.46

Maximum

Sep 30, 2020

51.63

Average

8.57

Median

EV/EBITDA Benchmark Analysis

The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
filtered constituents2.44K
min0.01
max40.82
average13.48
median11.75
std7.65